Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Clearside Biomedical First Quarter 2023 Financial Results and Corporate Update Call.

Related Keywords

Canada ,China ,Canadian ,Peter Chang ,Jenny Kobin ,Bausch Lomb ,Tom Chula ,Jonathan Wolleben ,Arshad Khanani ,Charlie Deignan ,Serge Belanger ,Charles Deignan ,Yi Chen ,Dennis Marcus ,George Lasezkay ,Suprachoroidal Microinjector ,Asia Pacific ,Lejla Vajzovic ,Annabel Samimy ,Andreas Argyrides ,Nasdaq ,Clearside Biomedical Inc ,Hc Wainwright Co ,Life Sciences Conference ,Clearside Biomedical ,Call Transcript May ,Clearside Biomedical First Quarter ,Corporate Update ,Private Securities Litigation Reform Act ,Risk Factors ,Annual Report ,Chief Executive Officer ,Chief Financial ,Dennis Marcus The ,Suprachoroidal Injection ,Arctic Vision ,Aura Biosciences ,Sciences Conference ,Wedbush Pacgrow Healthcare Conference ,Suprachoroidal Space ,